As Celgene (CELG) Share Value Declined, Shareholder Stratos Wealth Partners LTD Has Increased Position; As Taiwan Semiconductor (TSM) Stock Price Declined, Shareholder Thornburg Investment Management Cut by $754,908 Its Stake

Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) Logo

Stratos Wealth Partners Ltd increased its stake in Celgene Corp (CELG) by 14.49% based on its latest 2018Q3 regulatory filing with the SEC. Stratos Wealth Partners Ltd bought 3,839 shares as the company’s stock declined 22.96% with the market. The institutional investor held 30,325 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $2.71M, up from 26,486 at the end of the previous reported quarter. Stratos Wealth Partners Ltd who had been investing in Celgene Corp for a number of months, seems to be bullish on the $62.69 billion market cap company. The stock increased 1.83% or $1.61 during the last trading session, reaching $89.52. About 6.09 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 33.15% since February 11, 2018 and is downtrending. It has underperformed by 33.15% the S&P500. Some Historical CELG News: 13/03/2018 – FDA GRANTS PRIORITY REVIEW TO MERCK’S SBLA (SBLA) FOR KEYTRUDA®; 20/03/2018 – PROTHENA CORPORATION – PROTHENA TO RECEIVE A $100 MLN UPFRONT PAYMENT AND A $50 MLN EQUITY INVESTMENT BY CELGENE; 08/03/2018 – Moody’s Assigns Ratings To Five Classes Of Notes Issued By Crestline Denali Clo Xvi, Ltd; 30/04/2018 – FDA Grants Priority Review to Merck’s sBLA for KEYTRUDA® (pembrolizumab) in Combination with Pemetrexed (ALIMTA®) and; 06/04/2018 – Hagens Berman Alerts Investors in Celgene Corporation to the May 29, 2018 Lead Plaintiff Deadline in the Pending Securities Class Action and to the Abrupt Departure of Celgene’s President; 26/04/2018 – BRISTOL-MYERS CEO SAYS CONTINUES TO SEE BMS AS A GROWTH COMPANY AND OPDIVO AS A GROWTH FRANCHISE; 28/03/2018 – BLUEBIRD BIO INC – BLUEBIRD AND CELGENE WILL SHARE 50% OF U.S. COSTS AND PROFITS; 21/05/2018 – Wrestling with setbacks, Celgene adds $65M discovery alliance with Evotec to beef up on new cancer drugs $CELG; 17/05/2018 – Oncolytics Biotech® Announces Collaboration with Merck and Northwestern University Combining Keytruda® and REOLYSIN® in a Ph; 11/05/2018 – DENALI THERAPEUTICS INC – QTRLY SHR LOSS $0.26

Thornburg Investment Management Inc decreased its stake in Taiwan Semiconductor (TSM) by 27.26% based on its latest 2018Q3 regulatory filing with the SEC. Thornburg Investment Management Inc sold 17,157 shares as the company’s stock declined 18.35% with the market. The institutional investor held 45,774 shares of the semiconductors company at the end of 2018Q3, valued at $2.02 million, down from 62,931 at the end of the previous reported quarter. Thornburg Investment Management Inc who had been investing in Taiwan Semiconductor for a number of months, seems to be less bullish one the $187.88B market cap company. The stock increased 1.03% or $0.39 during the last trading session, reaching $38.18. About 3.12 million shares traded. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) has declined 6.61% since February 11, 2018 and is downtrending. It has underperformed by 6.61% the S&P500. Some Historical TSM News: 19/04/2018 – Taiwan Semiconductor Manufacturing (TMSC) said Thursday it expects second-quarter revenue to range between $7.8 billion and $7.9 billion, well below expectations; 01/05/2018 – TSMC’S NANJING PLANT STARTS MASS PRODUCTION: ECONOMIC DAILY; 15/05/2018 – Samsung in talks with ZTE, others to supply mobile processor chips – exec; 02/04/2018 – Taiwan Semi: Intel’s Apple Pain Could Be Its Gain — Barron’s Blog; 12/03/2018 – Moody’s: Upgrade Reflects Expectation That Growth in TSMC’s Free Cash Flow, Stability in Margins Will Remain Solid; 13/03/2018 – Luxtera Achieves Record Breaking Optical Performance with New TSV-Enabled Silicon Photonics Platform at TSMC; 23/05/2018 – TSMC starts producing A12 processors for next iPhone series, sources say; 09/03/2018 – Taiwan Semiconductor Manufacturing Feb Rev NT$64.64B; 02/04/2018 – TSMC 2330.TW TSM.N SAYS IT ORDERS MACHINERY EQUIPMENT WORTH T$29.4 BLN; 10/05/2018 – TSMC SAYS APRIL SALES +44.0 PCT ON YEAR

Investors sentiment increased to 0.93 in Q3 2018. Its up 0.22, from 0.71 in 2018Q2. It is positive, as 58 investors sold CELG shares while 418 reduced holdings. 113 funds opened positions while 332 raised stakes. 468.90 million shares or 1.67% less from 476.86 million shares in 2018Q2 were reported. John G Ullman And Associate Incorporated has 5,608 shares. Eastern Bancshares owns 7,000 shares. Beaumont Ptnrs Llc stated it has 15,531 shares or 0.14% of all its holdings. Logan Capital Mgmt invested 0.54% in Celgene Corporation (NASDAQ:CELG). Deutsche Bancorporation Ag holds 5.22 million shares or 0.32% of its portfolio. Rosenblum Silverman Sutton S F Ca reported 1.96% in Celgene Corporation (NASDAQ:CELG). 755,506 are held by Adage Prns Group Ltd Liability Corporation. Cap Advisors Ltd Limited Liability reported 0.01% stake. Orbimed Advsrs Ltd Liability Co reported 2.66% of its portfolio in Celgene Corporation (NASDAQ:CELG). Lucas Management has invested 2.35% of its portfolio in Celgene Corporation (NASDAQ:CELG). Opus Point Partners Mngmt Ltd Llc holds 9,747 shares. Prudential Public Ltd Liability holds 412,550 shares or 0.12% of its portfolio. Newman Dignan Sheerar holds 3,626 shares. Clearbridge Invs Ltd Liability invested in 7.13M shares or 0.55% of the stock. Loring Wolcott And Coolidge Fiduciary Advsrs Llp Ma stated it has 1.71% of its portfolio in Celgene Corporation (NASDAQ:CELG).

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 22 have Buy rating, 0 Sell and 13 Hold. Therefore 63% are positive. Celgene Corporation had 161 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by Citigroup given on Thursday, February 25. The firm has “Hold” rating given on Friday, May 5 by Argus Research. The rating was maintained by Citigroup with “Buy” on Thursday, September 29. As per Tuesday, November 8, the company rating was initiated by Mizuho. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Wednesday, December 13 by Leerink Swann. Leerink Swann maintained Celgene Corporation (NASDAQ:CELG) rating on Monday, May 7. Leerink Swann has “Buy” rating and $11500 target. Guggenheim maintained the stock with “Buy” rating in Thursday, December 21 report. PiperJaffray reinitiated it with “Neutral” rating and $133 target in Monday, October 23 report. Guggenheim maintained Celgene Corporation (NASDAQ:CELG) on Thursday, January 25 with “Buy” rating. The stock has “Neutral” rating by BTIG Research on Friday, December 21.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Nasdaq.com which released: “Pre-Market Earnings Report for January 31, 2019 : MA, DWDP, MO, GE, COP, UPS, CHTR, CELG, EPD, RTN, NOC, MMC – Nasdaq” on January 30, 2019, also Nasdaq.com with their article: “Celgene (CELG) Beats Q4 Earnings and Revenue Estimates – Nasdaq” published on January 31, 2019, Nasdaq.com published: “Can Celgene (CELG) Keep the Earnings Surprise Streak Alive? – Nasdaq” on January 21, 2019. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Nasdaq.com and their article: “Peek Under The Hood: IUSG Has 11% Upside – Nasdaq” published on January 31, 2019 as well as Nasdaq.com‘s news article titled: “Is Celgene (CELG) Outperforming Other Medical Stocks This Year? – Nasdaq” with publication date: January 25, 2019.

Stratos Wealth Partners Ltd, which manages about $2.15B and $2.24B US Long portfolio, decreased its stake in Copart Inc (NASDAQ:CPRT) by 27,408 shares to 455 shares, valued at $23,000 in 2018Q3, according to the filing. It also reduced its holding in Ishares Tr (FLOT) by 13,006 shares in the quarter, leaving it with 32,805 shares, and cut its stake in Pepsico Inc (NYSE:PEP).

More notable recent Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) news were published by: Seekingalpha.com which released: “TSMC’s dire guidance weighs on chips – Seeking Alpha” on January 17, 2019, also Fool.com with their article: “Does TSMC’s Slowdown Raise Red Flags for Chip Stocks? – Motley Fool” published on July 26, 2018, Benzinga.com published: “Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) – A Preview Of Taiwan Semiconductor’s Q3 Earnings – Benzinga” on October 17, 2018. More interesting news about Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) were released by: Finance.Yahoo.com and their article: “Is Taiwan Semiconductor Mfg. Co. Ltd. (TSM) Going to Burn These Hedge Funds? – Yahoo! Finance News” published on December 09, 2018 as well as Fool.com‘s news article titled: “Stock Market Power Rankings: Amazon Back on Top – The Motley Fool” with publication date: January 13, 2019.

Among 8 analysts covering Taiwan Semiconductor Manufacturing (NYSE:TSM), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. Taiwan Semiconductor Manufacturing had 19 analyst reports since August 24, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Wednesday, September 6 by KeyBanc Capital Markets. The company was upgraded on Tuesday, January 16 by HSBC. The rating was upgraded by J.P. Morgan on Tuesday, October 10 to “Buy”. HSBC downgraded the stock to “Hold” rating in Thursday, October 13 report. The firm earned “Buy” rating on Monday, January 22 by Goldman Sachs. The rating was maintained by Susquehanna with “Hold” on Thursday, January 18. The rating was upgraded by Susquehanna to “Neutral” on Tuesday, October 4. The stock has “Neutral” rating by Goldman Sachs on Tuesday, June 28. As per Monday, November 27, the company rating was downgraded by Morgan Stanley. As per Wednesday, June 21, the company rating was downgraded by HSBC.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart